{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:01:01Z","timestamp":1790146861111,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["R.12012\/05\/2023-HR\/E-Office: 8270784"],"award-info":[{"award-number":["R.12012\/05\/2023-HR\/E-Office: 8270784"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022833","name":"Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["Intramural Grant"],"award-info":[{"award-number":["Intramural Grant"]}],"id":[{"id":"10.13039\/100022833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12010-026-05773-z","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:18:42Z","timestamp":1781601522000},"page":"7538-7561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phytochemical Characterization of Tupistra nutans Inflorescence and its Cytostatic and Anti-Migratory Effect in Breast Cancer Cells"],"prefix":"10.1007","volume":"198","author":[{"given":"Bibhushan","family":"Dhungyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brintha","family":"S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Madhusoothanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-7128","authenticated-orcid":false,"given":"Priya","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"3","key":"5773_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., Sung, H., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. C Ca: A Cancer Journal For Clinicians, 74(3), 229\u2013263.","journal-title":"C Ca: A Cancer Journal For Clinicians"},{"issue":"4","key":"5773_CR2","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim, J., Harper, A., McCormack, V., et al. (2025). Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nature Medicine, 31(4), 1154\u20131162.","journal-title":"Nature Medicine"},{"key":"5773_CR3","doi-asserted-by":"crossref","unstructured":"Fu, X., Tan, W., Song, Q., Pei, H., & Li, J. (2022). BRCA1 and breast cancer: molecular mechanisms and therapeutic strategies. Frontiers in Cell and Developmental Biology, 10.","DOI":"10.3389\/fcell.2022.813457"},{"issue":"2","key":"5773_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","volume":"18","author":"MH Tan","year":"2012","unstructured":"Tan, M. H., Mester, J. L., Ngeow, J., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012). Lifetime cancer risks in individuals with germline PTEN mutations. Clinical Cancer Research, 18(2), 400\u2013407.","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"5773_CR5","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1053\/gast.2001.29611","volume":"121","author":"PDP Pharoah","year":"2001","unstructured":"Pharoah, P. D. P., Guilford, P., & Caldas, C. (2001). Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology, 121(6), 1348\u20131353.","journal-title":"Gastroenterology"},{"issue":"7","key":"5773_CR6","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1053\/j.gastro.2004.03.014","volume":"126","author":"W Lim","year":"2004","unstructured":"Lim, W., Olschwang, S., Keller, J. J., et al. (2004). Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology, 126(7), 1788\u20131794.","journal-title":"Gastroenterology"},{"issue":"43","key":"5773_CR7","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1038\/sj.onc.1209879","volume":"25","author":"AC Antoniou","year":"2006","unstructured":"Antoniou, A. C., & Easton, D. F. (2006). Models of genetic susceptibility to breast cancer. Oncogene, 25(43), 5898\u20135905.","journal-title":"Oncogene"},{"issue":"6","key":"5773_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/sj.onc.1201984","volume":"17","author":"MG FitzGerald","year":"1998","unstructured":"FitzGerald, M. G., Marsh, D. J., Wahrer, D., et al. (1998). Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene, 17(6), 727\u2013731.","journal-title":"Oncogene"},{"issue":"34","key":"5773_CR9","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","volume":"20","author":"JM Birch","year":"2001","unstructured":"Birch, J. M., Alston, R. D., McNally, R. J., et al. (2001). Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene, 20(34), 4621\u20134628.","journal-title":"Oncogene"},{"issue":"1","key":"5773_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.2007.53","volume":"40","author":"MR Stratton","year":"2008","unstructured":"Stratton, M. R., & Rahman, N. (2008). The emerging landscape of breast cancer susceptibility. Nature Genetics, 40(1), 17\u201322.","journal-title":"Nature Genetics"},{"issue":"4","key":"5773_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<354::AID-IJC4>3.0.CO;2-6","volume":"84","author":"DW Miles","year":"1999","unstructured":"Miles, D. W., Harris, W. H., Gillett, C. E., Smith, P., & Barnes, D. M. (1999). Effect of c-erbB2 and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide\/methotrexate\/fluorouracil. International Journal Of Cancer, 84(4), 354\u2013359.","journal-title":"International Journal Of Cancer"},{"issue":"2","key":"5773_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1040-8428(01)00191-3","volume":"44","author":"F Lerebours","year":"2002","unstructured":"Lerebours, F., & Lidereau, R. (2002). Molecular alterations in sporadic breast cancer. Critical Reviews In Oncology Hematology, 44(2), 121\u2013141.","journal-title":"Critical Reviews In Oncology Hematology"},{"issue":"12","key":"5773_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/nm1295-1257","volume":"1","author":"D Weinstat-Saslow","year":"1995","unstructured":"Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., et al. (1995). Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Medicine, 1(12), 1257\u20131260.","journal-title":"Nature Medicine"},{"issue":"15","key":"5773_CR14","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent, R., Trudeau, M., Pritchard, K. I., et al. (2007). Triple-negative breast cancer: Clinical features and patterns of recurrence. Clinical Cancer Research, 13(15), 4429\u20134434.","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"5773_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2202809","volume":"387","author":"J Cortes","year":"2022","unstructured":"Cortes, J., Rugo, H. S., Cescon, D. W., et al. (2022). Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. New England Journal Of Medicine, 387(3), 217\u2013226.","journal-title":"New England Journal Of Medicine"},{"issue":"1","key":"5773_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13550-022-00932-9","volume":"12","author":"RA Sankaranarayanan","year":"2022","unstructured":"Sankaranarayanan, R. A., Florea, A., Allekotte, S., et al. (2022). PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer. EJNMMI Res, 12(1), 60.","journal-title":"EJNMMI Res"},{"issue":"11","key":"5773_CR17","doi-asserted-by":"publisher","first-page":"djw148","DOI":"10.1093\/jnci\/djw148","volume":"108","author":"P ter Brugge","year":"2016","unstructured":"ter Brugge, P., Kristel, P., van der Burg, E., et al. (2016). Mechanisms of therapy resistance in patient-derived xenograft models of BRCA1-deficient breast cancer. Journal Of The National Cancer Institute, 108(11), djw148.","journal-title":"Journal Of The National Cancer Institute"},{"key":"5773_CR18","first-page":"229","volume":"18","author":"A Jen\u010da","year":"2024","unstructured":"Jen\u010da, A., Mills, D., Ghasemi, H., et al. (2024). Herbal therapies for cancer treatment: A review of phytotherapeutic efficacy. Biologics, 18, 229\u2013255.","journal-title":"Biologics"},{"issue":"7","key":"5773_CR19","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","volume":"15","author":"O Obidiro","year":"2023","unstructured":"Obidiro, O., Battogtokh, G., & Akala, E. O. (2023). Triple negative breast cancer treatment options and limitations: Future outlook. Pharmaceutics, 15(7), 1796.","journal-title":"Pharmaceutics"},{"key":"5773_CR20","doi-asserted-by":"crossref","unstructured":"Hsu, M. Y., Hsieh, C. H., Huang, Y. T. (2021). Enhanced paclitaxel efficacy to suppress triple-negative breast cancer progression using metronomic chemotherapy with a controlled-release system of electrospun poly-d-l-lactide-co-glycolide (PLGA) nanofibers. Cancers (Basel), 13(13).","DOI":"10.3390\/cancers13133350"},{"issue":"10","key":"5773_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41416-021-01683-5","volume":"126","author":"S Saurav","year":"2022","unstructured":"Saurav, S., & Manna, S. K. (2022). Increased expression of profilin potentiates chemotherapeutic agent-mediated tumour regression. British Journal Of Cancer, 126(10), 1410\u20131420.","journal-title":"British Journal Of Cancer"},{"issue":"8","key":"5773_CR22","doi-asserted-by":"publisher","first-page":"e37264","DOI":"10.1097\/MD.0000000000037264","volume":"103","author":"Z Chen","year":"2024","unstructured":"Chen, Z., Lu, P., Li, M., et al. (2024). Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysis. Medicine (Baltimore), 103(8), e37264.","journal-title":"Medicine (Baltimore)"},{"key":"5773_CR23","doi-asserted-by":"crossref","unstructured":"Gonzalez Suarez, N., Fernandez-Marrero, Y., H\u00e9bert, M. P. A. (2023). EGCG inhibits the inflammation and senescence-inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles. Cancer Cell International, 23(1).","DOI":"10.1186\/s12935-023-03087-2"},{"issue":"4","key":"5773_CR24","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1158\/1078-0432.CCR-06-1277","volume":"13","author":"M Huang","year":"2007","unstructured":"Huang, M., Gao, H., Chen, Y., et al. (2007). Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clinical Cancer Research, 13(4), 1298\u20131307.","journal-title":"Clinical Cancer Research"},{"issue":"25","key":"5773_CR25","doi-asserted-by":"publisher","first-page":"40434","DOI":"10.18632\/oncotarget.17107","volume":"8","author":"K Szarc vel Szic","year":"2017","unstructured":"Szarc vel Szic, K., Declerck, K., Crans, R. A. J., et al. (2017). Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. Oncotarget, 8(25), 40434\u201340453.","journal-title":"Oncotarget"},{"key":"5773_CR26","unstructured":"Linh, N. T., Ha, N. M., & Son, N. T. (2022). Genus Tupistra: a comprehensive review of phytochemistry and pharmacological activity. Natural Product Communications, 17(1)."},{"key":"5773_CR27","doi-asserted-by":"publisher","first-page":"102819","DOI":"10.1016\/j.bcab.2023.102819","volume":"52","author":"AC Roy","year":"2023","unstructured":"Roy, A. C., Prasad, A., Singh, S., et al. (2023). Comparative bioactivity analysis of hydro-methanolic extracts of root, leaf, and inflorescence of Tupistra nutans Wall ex Lindl: an in vitro study on antioxidant and anti-hepatocellular carcinoma activity. Biocatalysis And Agricultural Biotechnology, 52, 102819.","journal-title":"Biocatalysis And Agricultural Biotechnology"},{"issue":"1","key":"5773_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12010-022-04145-7","volume":"195","author":"AC Roy","year":"2023","unstructured":"Roy, A. C., Prasad, A., & Ghosh, I. (2023). Phytochemical profiling of Tupistra nutans Wall ex Lindl. inflorescence extract and evaluation of its antioxidant activity and toxicity in hepatocarcinoma (HepG2) and fibroblast (F111) cells. Applied Biochemistry And Biotechnology, 195(1), 172\u2013195.","journal-title":"Applied Biochemistry And Biotechnology"},{"issue":"3","key":"5773_CR29","first-page":"51","volume":"3","author":"S Bissa","year":"2011","unstructured":"Bissa, S., & Bohra, A. (2011). Antibacterial potential of pot marigold. J Microbiol Antimicrob, 3(3), 51\u201354.","journal-title":"J Microbiol Antimicrob"},{"issue":"4","key":"5773_CR30","first-page":"192","volume":"6","author":"S Brintha","year":"2017","unstructured":"Brintha, S., Renuka, R., Rajesh, S., Santhanakrishnan, V. P., & Gnanam, R. (2017). Phytochemical analysis and bioactivity prediction of compounds in methanolic extracts of Curculigo orchioides Gaertn. J Pharmacogn Phytochem, 6(4), 192\u2013197.","journal-title":"J Pharmacogn Phytochem"},{"issue":"3","key":"5773_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"DA Filimonov","year":"2014","unstructured":"Filimonov, D. A., Lagunin, A. A., Gloriozova, T. A., Rudik, A. V., Druzhilovskii, D. S., Pogodin, P. V., & Poroikov, V. V. (2014). Prediction of the Biological Activity Spectra of Organic Compounds Using the PASS Online Web Resource. Chemistry Of Heterocyclic Compounds, 50(3), 444\u2013457.","journal-title":"Chemistry Of Heterocyclic Compounds"},{"issue":"2","key":"5773_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang, C. C., Park, A. Y., & Guan, J. L. (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols, 2(2), 329\u2013333. https:\/\/doi.org\/10.1038\/nprot.2007.30","journal-title":"Nature Protocols"},{"issue":"10","key":"5773_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s13205-023-03759-w","volume":"13","author":"A Prasad","year":"2023","unstructured":"Prasad, A., Roy, A. C., Priya, K., Meena, R., & Ghosh, I. (2023). Effect of differential deprivation of nutrients on cellular proliferation, oxidative stress, mitochondrial function, and cell migration in MDA-MB-231, HepG2, and HeLa cells. 3 Biotech, 13(10), 339. https:\/\/doi.org\/10.1007\/s13205-023-03759-w","journal-title":"3 Biotech"},{"key":"5773_CR34","unstructured":"Tchounwou, P. B., Dasari, S., Noubissi, F. K. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. Journal of Experimental Pharmacology."},{"issue":"1","key":"5773_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive, P. L., & Ban\u00e1th, J. P. (2006). The comet assay: a method to measure DNA damage in individual cells. Nature Protocols, 1(1), 23\u201329.","journal-title":"Nature Protocols"},{"issue":"11","key":"5773_CR36","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1002\/tox.24388","volume":"39","author":"K Priya","year":"2024","unstructured":"Priya, K., Roy, A. C., Prasad, A., Kumar, P., & Ghosh, I. (2024). Naringenin against cadmium toxicity in fibroblast cells: an integrated network pharmacology and in vitro metabolomics approach. Environmental Toxicology, 39(11), 5124\u20135139. https:\/\/doi.org\/10.1002\/tox.24388","journal-title":"Environmental Toxicology"},{"issue":"4","key":"5773_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2^\u2013\u2206\u2206CT method. Methods, 25(4), 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"5773_CR38","doi-asserted-by":"crossref","unstructured":"Somasundaram, V., Hemalatha, S. K., Pal, K. (2016). Selective mode of action of plumbagin through BRCA1-deficient breast cancer stem cells. BMC Cancer, 16(1):336. 2021;13:303\u2013328.","DOI":"10.1186\/s12885-016-2372-4"},{"issue":"2","key":"5773_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/14786419.2013.838240","volume":"28","author":"LM Wei","year":"2014","unstructured":"Wei, L. M., Wu, Y. C., Chen, C. C., et al. (2014). Tupichinins B\u2013D, three new spirostanol saponins from Tupistra chinensis rhizomes. Natural Product Research, 28(2), 74\u201380.","journal-title":"Natural Product Research"},{"key":"5773_CR40","unstructured":"World Health Organization (2007). WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. World Health Organization."},{"issue":"5","key":"5773_CR41","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s43441-023-00532-2","volume":"57","author":"I Inada","year":"2023","unstructured":"Inada, I., Kiuchi, F., & Urushihara, H. (2023). Comparison of regulations for arsenic and heavy metals in herbal medicines using pharmacopoeias of nine countries\/regions. Ther Innov Regul Sci, 57(5), 963\u2013974. https:\/\/doi.org\/10.1007\/s43441-023-00532-2","journal-title":"Ther Innov Regul Sci"},{"issue":"3","key":"5773_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/medicina58030431","volume":"58","author":"L Coregliano-Ring","year":"2022","unstructured":"Coregliano-Ring, L., Goia-Nishide, K., & Rangel, \u00c9. B. (2022). Hypokalemia in diabetes mellitus setting. Medicina (B Aires), 58(3), 431.","journal-title":"Medicina (B Aires)"},{"issue":"4","key":"5773_CR43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ijc.24419","volume":"125","author":"S Srinivasan","year":"2009","unstructured":"Srinivasan, S., Koduru, S., Kumar, R., et al. (2009). Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. International Journal Of Cancer, 125(4), 961\u2013967.","journal-title":"International Journal Of Cancer"},{"key":"5773_CR44","doi-asserted-by":"publisher","first-page":"102674","DOI":"10.1016\/j.bcab.2023.102674","volume":"50","author":"AC Roy","year":"2023","unstructured":"Roy, A. C., Prasad, A., Priya, K., Das, P., Singh, S., Ghosh, C., & Ghosh, I. (2023). Anticancer effect of antioxidant-rich methanolic extract of Rauvolfia serpentina (L.) Benth. ex Kurz leaves in HepG2 and HeLa cells: a mechanistic insight. Biocatalysis And Agricultural Biotechnology, 50, 102674. https:\/\/doi.org\/10.1016\/j.bcab.2023.102674","journal-title":"Biocatalysis And Agricultural Biotechnology"},{"issue":"6","key":"5773_CR45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.dnarep.2006.03.009","volume":"5","author":"S Mogi","year":"2006","unstructured":"Mogi, S., & Oh, D. H. (2006). \u03b3-H2AX formation in response to interstrand crosslinks requires XPF in human cells. DNA Repair (Amst), 5(6), 731\u2013740.","journal-title":"DNA Repair (Amst)"},{"key":"5773_CR46","doi-asserted-by":"crossref","unstructured":"Wang, T., Li, Z., Yan, L. (2021). Long non-coding RNA Neighbor of BRCA1 Gene 2: a crucial regulator in cancer biology. Frontiers in Oncology ,11.","DOI":"10.3389\/fonc.2021.783526"},{"issue":"4","key":"5773_CR47","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/sj.onc.1204078","volume":"20","author":"TC Suen","year":"2001","unstructured":"Suen, T. C., & Goss, P. E. (2001). Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene. Oncogene, 20(4), 440\u2013450.","journal-title":"Oncogene"},{"key":"5773_CR48","doi-asserted-by":"crossref","unstructured":"Yu, H., Xie, Y., Zhou, Z. (2019). Curcumin regulates the progression of colorectal cancer via LncRNA NBR2\/AMPK pathway. Technology in Cancer Research & Treatment, 18.","DOI":"10.1177\/1533033819870781"},{"issue":"3","key":"5773_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40415-019-00547-w","volume":"42","author":"IM Chung","year":"2019","unstructured":"Chung, I. M., Chelliah, R., Oh, D. H., et al. (2019). Tupistra nutans Wall. root extract, rich in phenolics, inhibits microbial growth and \u03b1-glucosidase activity, while demonstrating strong antioxidant potential. Braz J Bot, 42(3), 383\u2013397.","journal-title":"Braz J Bot"},{"key":"5773_CR50","doi-asserted-by":"publisher","unstructured":"Datta, S., Bhattacharjee, S., Ghosh, S., et al. (2025). Validating the antidiabetic potential of Nakima (Tupistra clarkei Hook.f.), a traditional food from eastern Himalayan region, through network pharmacology and in vivo experimentation. Journal of Pharmacy and Pharmacology, Published online May\u202f7,\u202f2025. https:\/\/doi.org\/10.1093\/jpp\/rgaf014","DOI":"10.1093\/jpp\/rgaf014"},{"key":"5773_CR51","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s41417-025-00969-7","volume":"32","author":"D Patra","year":"2025","unstructured":"Patra, D., Varghese, G. R., Jaikumar, V. S., Rajan, A., Krishnan, N., Kuppuswamy, K., Thankappan, R., & Srinivas, P. (2025). Decoding BRCA1 promoter hypermethylation: a new frontier in understanding sporadic breast cancer. Cancer Gene Therapy, 32, 1400\u20131413. https:\/\/doi.org\/10.1038\/s41417-025-00969-7","journal-title":"Cancer Gene Therapy"},{"issue":"4","key":"5773_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ncb3328","volume":"18","author":"X Liu","year":"2016","unstructured":"Liu, X., Xiao, Z. D., Han, L., et al. (2016). LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nature Cell Biology, 18(4), 431\u2013442.","journal-title":"Nature Cell Biology"},{"issue":"8","key":"5773_CR53","doi-asserted-by":"publisher","first-page":"119041","DOI":"10.1016\/j.bbamcr.2021.119041","volume":"1868","author":"M Redza-Dutordoir","year":"2021","unstructured":"Redza-Dutordoir, M., & Averill-Bates, D. A. (2021). Interactions between reactive oxygen species and autophagy. Biochim Biophys Acta Mol Cell Res, 1868(8), 119041.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"5773_CR54","doi-asserted-by":"publisher","first-page":"111023","DOI":"10.1016\/j.biopha.2020.111023","volume":"133","author":"JQ Sheng","year":"2021","unstructured":"Sheng, J. Q., Wang, M. R., Fang, D., et al. (2021). LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma. Biomedicine & Pharmacotherapy, 133, 111023.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"5773_CR55","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/nu6020466","volume":"6","author":"J Fiedor","year":"2014","unstructured":"Fiedor, J., & Burda, K. (2014). Potential role of carotenoids as antioxidants in human health and disease. Nutrients, 6(2), 466\u2013488.","journal-title":"Nutrients"},{"key":"5773_CR56","doi-asserted-by":"publisher","first-page":"109004","DOI":"10.1016\/j.biopha.2019.109004","volume":"116","author":"Z Tavsan","year":"2019","unstructured":"Tavsan, Z., & Kayali, H. A. (2019). Flavonoids showed anticancer effects on the ovarian cancer cells: involvement of reactive oxygen species, apoptosis, cell cycle and invasion. Biomedicine & Pharmacotherapy, 116, 109004.","journal-title":"Biomedicine & Pharmacotherapy"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05773-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05773-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05773-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:14:22Z","timestamp":1790144062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05773-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5773"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05773-z","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"1 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}